Researchers have found that severe pneumonia decreases by 35 per cent in children who receive a vaccine against pneumonia-causing bacteria. The research presented at the World congress of the World Society for Pediatric Infectious Diseases in philippines was among the first to evaluate pneumococcal vaccines in Asia, as pneumococcus was often overlooked as a cause of pneumonia because it is challenging to detect.
The study, a collaborative effort between the Murdoch Children's Research Institute (MCRI) and the university of melbourne along with colleagues in the Asia-Pacific region, shows pneumonia is the most common reason why children are admitted to hospital in laos, with most requiring treatment with oxygen, especially young infants.
"One of the main causes of death from pneumonia is a lack of oxygen in the blood. Supplementary oxygen is a life-saving therapy that is unfortunately not consistently available across hospitals in laos," she said. professor Russell said her team had developed a new method using data collected from a hospital in laos, to demonstrate that the vaccine worked against the severest form of pneumonia.